Cargando…
Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is one of the most malignant tumors. The study was carried out to investigate the prognostic value of Beclin 1, EGFR and ALK for this cancer. Patients diagnosed with non-squamous NSCLC and admitted to our hospital from January 2011 to September 2016 were analyzed....
Autores principales: | Wan, Yanhui, Qian, Youhui, Wang, Youyu, Fang, Fuyuan, Wu, Guodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675885/ https://www.ncbi.nlm.nih.gov/pubmed/36401689 http://dx.doi.org/10.1007/s12672-022-00586-y |
Ejemplares similares
-
LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival
por: Wan, Yanhui, et al.
Publicado: (2021) -
Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis
por: Wang, Youyu, et al.
Publicado: (2021) -
Establishing an 8‐gene immune prognostic model based on TP53 status for lung adenocarcinoma
por: Wu, Guodong, et al.
Publicado: (2022) -
Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations
por: Lou, Na-Na, et al.
Publicado: (2016) -
Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
por: Rothschild, Sacha I.
Publicado: (2015)